Clinical trials
Phase 1 Multiple Sclerosis, Chronic Progressive trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2024 | 7 |
| 2025 | 2 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Recruiting | 5 |
| Unknown status | 4 |
| Active, not recruiting | 3 |
| Not yet recruiting | 3 |
| Withdrawn | 2 |
| Suspended | 1 |
| Terminated | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genzyme, a Sanofi Company | 2 |
| Johns Hopkins University | 2 |
| Stanford University | 2 |
| Abata Therapeutics | 1 |
| American CryoStem Corporation | 1 |
| Artielle ImmunoTherapeutics | 1 |
| Autolus Limited | 1 |
| Biogen | 1 |
| Bruce Cree | 1 |
| Casa Sollievo della Sofferenza IRCCS | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis, Chronic Progressive | 36 |
| Multiple Sclerosis | 24 |
| Multiple Sclerosis, Relapsing-Remitting | 9 |
| Autoimmune Diseases | 5 |
| Autoimmune Diseases of the Nervous System | 3 |
| Demyelinating Diseases | 3 |
| Demyelinating Autoimmune Diseases, CNS | 2 |
| Immune System Diseases | 2 |
| Lupus Erythematosus, Systemic | 2 |
| Nervous System Diseases | 2 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.